The lung function profile of once-daily tiotropium and olodaterol via respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via a accuhaler® (Energito® study)

  1. Beeh, K.-M.
  2. Derom, E.
  3. Echave-Sustaeta, J.
  4. Grönke, L.
  5. Hamilton, A.
  6. Zhai, D.
  7. Bjermer, L.
Aldizkaria:
International Journal of COPD

ISSN: 1178-2005 1176-9106

Argitalpen urtea: 2016

Alea: 11

Orrialdeak: 193-205

Mota: Artikulua

DOI: 10.2147/COPD.S95055 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak